British Leprosy Relief Association
Decompressive surgery for treating nerve damage in leprosy. A Cochrane review
N. H. J. van Veen et al.
Review of surgery for nerve damage
Van VeenNatasja H.J.a
aDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
bRehabilitation Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands
cPlastic Surgery, Regional Hospitals of Apeldoorn, Deventer and Zutphen, Apeldoorn, The Netherlands
dDivision of Neurosurgery, Datta Meghe Institute of Medical Sciences, Wardha, India
Correspondence to: Natasja H. J. van Veen, Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA, The Netherlands (e-mail: email@example.com)
Decompressive surgery is used for treating nerve damage in leprosy. We assessed the effectiveness of decompressive surgery for patients with nerve damage due to leprosy.
A broad search strategy was performed to find eligible studies, selecting randomised controlled trials (RCTs) comparing decompressive surgery alone or plus corticosteroids with corticosteroids alone, placebo or no treatment. Two authors independently assessed quality and extracted data. Where it was not possible to perform a meta-analysis, the data for each trial was summarised.
We included two randomised controlled trials involving 88 people. The trials examined the added benefit of surgery over prednisolone for treatment of nerve damage of less than 6 months duration. After 2 years follow-up there was no significant difference in nerve function improvement between people treated with surgery plus prednisolone or with prednisolone alone. Adverse effects of decompression surgery were not adequately described.
Evidence from randomised controlled trials does not show a significant added benefit of surgery over steroid treatment alone. Well-designed randomised controlled trials are needed to establish the effectiveness of the combination of surgery and medical treatment compared to medical treatment alone.